The French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD): Translation and validation in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD).
Objective: To provide and validate a French translation of the MDT-PD in the Luxembourgish multilingual population, in terms of linguistic, test-retest-, language reliability and sensitivity.…Comparative Age-Relatedness of Dyskinesia, Dystonia and Ataxia Rating Scales in Healthy Children
Objective: In healthy children (4-16 years of age), we aimed to associate DIS scores with age, and compare age-related influences on dyskinesia (DIS), dystonia (BFMDRS)…Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS)
Objective: Test if differential item functioning (DIF) due to gender, age, race/ethnicity or education level is present in UDysRS items. Background: Testing a rating…The 3-step clinical prediction tool for falls in Parkinson’s disease: can it be used as a self-assessment measure?
Objective: To determine if people with Parkinson’s disease (PD) are able to estimate their gait speed relative to a threshold speed of 1.1 m/s. Background:…Translating the Rapid Eye Movement (REM) Sleep Behavior Disorder Screening Questionnaire (RBDSQ) into 21 Languages Using a Standardized Methodology
Objective: The objectives of this study were to present the method and the challenges of the Rapid Eye Movement (REM) Sleep Behavior Disorder Screening Questionnaire…Translating the Parkinson´s Disease Sleep Scale (PDSS-2) into 31 Languages Using a Standardized Methodology
Objective: The objectives of this study are to present the method and the challenges of the translation of the Parkinson´s Disease Sleep Scale (PDSS-2) (originally…The Corticobasal Degeneration Functional Rating Scale (CBD-FS)
Objective: To develop a patient/care giver-reported scale that is capable of assessing functional disability in CBD that can be easily and reliably used in clinical…A Comparison of Muscular Atrophy Between Botulinum Toxin Types A and B
Objective: To compare and quantify the degree of muscular atrophy (MA) in botulinum toxin (BT) type A (Botox) and type B (Myobloc). A secondary endpoint…The Adult Spasticity International Registry (ASPIRE) Study: 1 Year Results
Objective: To evaluate the 1-year interim onabotulinumtoxinA safety, effectiveness, and exploratory treatment utilization data from the ASPIRE study. Background: OnabotulinumtoxinA treatment for patients with spasticity…The Adult Spasticity International Registry (ASPIRE) Study: Treatment Utilization Patterns in Patients Treated for Both Upper and Lower Limb Spasticity
Objective: To examine the treatment patterns of onabotulinumtoxinA utilization in patients treated for upper and lower limb spasticity, in combination, from the ASPIRE study (1…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.